Novel drug for oral treatment against Covid-19
Nature Microbiology reported on an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801, that was repurposed for use against
Category: Drug delivery
Marinus Pharmaceuticals Provides SBECD-enabled Ganaxolone Clinical Data
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced it
Top-line final data from CD-enabled Cantrixil Phase I study confirms prior positive efficacy and safety signals
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company shared top-line final data from its phase I study of Cantrixil (TRX-E-002-1)
Fast-Dissolving Cyclodextrin/Antibiotic Nanofibers for Oral Antibiotics Delivery
J. Colloid Interface Sci. recently published an article reporting the development of fast-dissolving CD/antibiotics inclusion complex (IC) nanofibers for oral
Method for HPBCD analysis in pharmaceutical formulations
Hydroxypropyl-β-cyclodextrin is added to pharmaceuticals, including vaccines, to improve the solubility in water, stabilizing, etc. It is also expected to
Chapter 7: Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery
This chapter reviews major critical research on cyclodextrin-based nanoparticles to explain their versatility and high potential for advanced drug delivery,
Chapter 6: Cyclodextrin-Based Polymers for Food and Pharmaceutical Applications: A Historical Review
The chapter discusses, from a historical perspective, the evolution of the synthesis procedures to prepare covalently linked cyclodextrins, either by
Utility of aspirin in hospitalized COVID-19 patients
A recent paper published in Anesthesia & Analgesia Journal evaluated the possible benefits of using aspirin in hospitalized COVID-19 patients
Inclusion complex based on N-acetyl-L-cysteine and arginine modified hydroxypropyl-β-cyclodextrin for oral insulin delivery
Insulin is the most effective drug in the treatment of diabetes mellitus. At present, subcutaneous injection is still the common
FIRST EXPERIMENTS IN SPACE FOR COVID-19 DRUG RESEARCH
The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by